SAILING CAPITAL OVERSEAS INVESTMENTS FUND, LP enters CELLULAR BIOMEDICINE GROUP, INC. with 1.71M shares across direct and indirect positions
This filing by SAILING CAPITAL OVERSEAS INVESTMENTS FUND, LP establishes the baseline for all future Form 4 insider transaction reports at CELLULAR BIOMEDICINE GROUP, INC..
Indirect
Filed: 2/28/2020ACC: 0000902664-20-001369
→
10% Owner
Since Feb 2020
1.71M
Baseline shares
0.00
Direct ownership
0 positions
0.00
Derivative underlying
0 instruments
1
Security positions
1.71M indirect
Non-Derivative Holdings1
Common Stock
IndirectShares owned1.71M
Total
1.71M indirect1.71M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.71M | Indirect |
| Total | 1.71M | 1.71M indirect |
Derivative Holdings0
No derivative holdings reported